Loading clinical trials...
Loading clinical trials...
The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team
Age
35 - No limit years
Sex
ALL
Healthy Volunteers
No
Research Site
Aarhus, Arhus, Denmark
Research Site
Bjerringbro, Viborg, Denmark
Research Site
Møldrup, Viborg, Denmark
Research Site
Skals, Viborg, Denmark
Research Site
Aalborg, Denmark
Research Site
Klarup, Denmark
Research Site
Skive, Denmark
Research Site
Spøttrup, Denmark
Research Site
Stoholm, Denmark
Research Site
Viborg, Denmark
Start Date
October 1, 2008
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
February 23, 2011
936
ACTUAL participants
Lead Sponsor
AstraZeneca
NCT07477600
NCT07462221
NCT07351929
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions